Cash flows from operating activities | |
Net loss attributable to common stockholders | |
Adjustments to reconcile net loss attributable to common stockholders to net cash provided by (used in) operating activities: | |
Gain on sale of limited partnership investment | |
Loss on early extinguishment of debt | |
Depreciation, depletion and amortization | 106.08M |
Amortization of debt issuance and debt discount | 38.83M |
Non-cash compensation | 85.13M |
Investment in (use of) restricted cash and cash equivalents | 119.83M |
Non-cash derivative gain | |
Non-controlling interest | -60.16M |
Non-cash interest expense | |
Use of cash for accrued interest | |
Other | 9.8M |
Changes in operating assets and liabilities: | |
Accounts payable and accrued liabilities | 39.6M |
LNG inventory | -28.05M |
Accounts and interest receivable | -128.04M |
Deferred revenue | -2.96M |
Prepaid expenses and other | 47.63M |
Net cash provided by (used in) operating activities | -199.03M |
Cash flows from investing activities | |
Proceeds from sale of limited partnership investment | |
Use of restricted cash and cash equivalents | 3.49B |
LNG terminal and pipeline construction-in-process, net | -3.45B |
Distributions from limited partnership investment | |
Other | -51.31M |
Net cash provided by (used in) investing activities | -12.21M |
Cash flows from financing activities | |
Sale of common stock, net | |
Debt repurchases | |
Use of restricted cash and cash equivalents | -3.93B |
Distributions to non-controlling interest | |
Sale of common units by restricted affiliate | |
Purchase of treasury shares | |
Other | -317K |
Net cash provided by (used in) financing activities | 253K |
Net increase (decrease) in cash and cash equivalents | -210.98M |
Cash and cash equivalents—beginning of period | 1.2B |
Cash and cash equivalents—end of period | 990.13M |